Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England.

Campbell H, Andrews N, Parikh S, Ribeiro S, Gray S, Lucidarme J, Ramsay ME, Borrow R, Ladhani SN.

J Infect. 2019 Nov 9. pii: S0163-4453(19)30339-1. doi: 10.1016/j.jinf.2019.11.001. [Epub ahead of print]

PMID:
31715210
2.

Prevention and control of meningococcal disease: updates from the Global Meningococcal Initiative in Eastern Europe.

Bai X, Borrow R, Bukovski S, Caugant DA, Culic D, Delic S, Dinleyici EC, Eloshvili M, Erdősi T, Galajeva J, Křížová P, Lucidarme J, Mironov K, Nurmatov Z, Pana M, Rahimov E, Savrasova L, Skoczyńska A, Smith V, Taha MK, Titov L, Vázquez J, Yeraliyeva L.

J Infect. 2019 Nov 1. pii: S0163-4453(19)30332-9. doi: 10.1016/j.jinf.2019.10.018. [Epub ahead of print]

PMID:
31682877
3.

Comparative genomic analyses of Chinese serogroup W ST-11 complex Neisseria meningitidis isolates.

Zhu B, Lucidarme J, Bai X, Guo P, Zhang A, Borrow R, Gao W, Xu L, Gao Y, Shao Z.

J Infect. 2019 Aug 29. pii: S0163-4453(19)30259-2. doi: 10.1016/j.jinf.2019.08.019. [Epub ahead of print]

PMID:
31473270
4.

Outbreak strain characterisation and pharyngeal carriage detection following a protracted group B meningococcal outbreak in adolescents in South-West England.

Clark SA, Lucidarme J, Angel G, Lekshmi A, Morales-Aza B, Willerton L, Campbell H, Gray SJ, Ladhani SN, Wade M, Ramsay M, Yates J, Finn A, Borrow R.

Sci Rep. 2019 Jul 10;9(1):9990. doi: 10.1038/s41598-019-46483-3.

5.

Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017).

Ladhani SN, Campbell H, Lucidarme J, Gray S, Parikh S, Willerton L, Clark SA, Lekshmi A, Walker A, Patel S, Bai X, Ramsay M, Borrow R.

BMC Infect Dis. 2019 Jun 14;19(1):522. doi: 10.1186/s12879-019-4146-5.

6.

Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015.

Lawler J, Lucidarme J, Parikh S, Smith L, Campbell H, Borrow R, Gray S, Foster K, Ladhani S.

Euro Surveill. 2019 Jun;24(23). doi: 10.2807/1560-7917.ES.2019.24.23.1900070.

7.

Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 Lineage.

Green LR, Dave N, Adewoye AB, Lucidarme J, Clark SA, Oldfield NJ, Turner DPJ, Borrow R, Bayliss CD.

J Infect Dis. 2019 Aug 30;220(7):1109-1117. doi: 10.1093/infdis/jiz275.

8.

Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.

Lucidarme J, Louth J, Townsend-Payne K, Borrow R.

Methods Mol Biol. 2019;1969:169-179. doi: 10.1007/978-1-4939-9202-7_12.

PMID:
30877677
9.

Viable Neisseria meningitidis is commonly present in saliva in healthy young adults: Non-invasive sampling and enhanced sensitivity of detection in a follow-up carriage study in Portuguese students.

Rodrigues F, Christensen H, Morales-Aza B, Sikora P, Oliver E, Oliver J, Lucidarme J, Marlow R, Januário L, Finn A.

PLoS One. 2019 Feb 11;14(2):e0209905. doi: 10.1371/journal.pone.0209905. eCollection 2019.

10.

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.

Findlow H, Campbell H, Lucidarme J, Andrews N, Linley E, Ladhani S, Borrow R.

Euro Surveill. 2019 Jan;24(1). doi: 10.2807/1560-7917.ES.2019.24.1.1700818.

11.

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.

Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, Echaniz-Aviles G, Hakawi A, Kamiya H, Karachaliou A, Lucidarme J, Meiring S, Mironov K, Sáfadi MAP, Shao Z, Smith V, Steffen R, Stenmark B, Taha MK, Trotter C, Vázquez JA, Zhu B.

Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27. Review.

PMID:
30526162
12.

Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt.

Diallo K, Coulibaly MD, Rebbetts LS, Harrison OB, Lucidarme J, Gamougam K, Tekletsion YK, Bugri A, Toure A, Issaka B, Dieng M, Trotter C, Collard JM, Sow SO, Wang X, Mayer LW, Borrow R, Greenwood BM, Maiden MCJ, Manigart O; MenAfriCar Consortium.

PLoS One. 2018 Dec 5;13(12):e0206453. doi: 10.1371/journal.pone.0206453. eCollection 2018.

13.

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland.

Mulhall RM, Bennett D, Cunney R, Borrow R, Lucidarme J, Findlow J, Jolley KA, Bray J, Maiden MCJ, Moschioni M, Serino L, Stella M, Medini D.

mSphere. 2018 Aug 22;3(4). pii: e00196-18. doi: 10.1128/mSphere.00196-18.

14.

Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine.

Green LR, Lucidarme J, Dave N, Chan H, Clark S, Borrow R, Bayliss CD.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00204-18. doi: 10.1128/JCM.00204-18. Print 2018 Sep.

15.

Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines.

Cayrou C, Akinduko AA, Mirkes EM, Lucidarme J, Clark SA, Green LR, Cooper HJ, Morrissey J, Borrow R, Bayliss CD.

PLoS One. 2018 May 30;13(5):e0197186. doi: 10.1371/journal.pone.0197186. eCollection 2018.

16.

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016.

Rodrigues CMC, Lucidarme J, Borrow R, Smith A, Cameron JC, Moxon ER, Maiden MCJ.

Emerg Infect Dis. 2018 Apr;24(4):673-682. doi: 10.3201/eid2404.171480.

17.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.

Knol MJ, Hahné SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, Borrow R, Ladhani SN, Ramsay ME, van der Ende A.

Lancet Public Health. 2017 Oct;2(10):e473-e482. doi: 10.1016/S2468-2667(17)30157-3. Epub 2017 Aug 24.

18.

Targeted DNA enrichment and whole genome sequencing of Neisseria meningitidis directly from clinical specimens.

Clark SA, Doyle R, Lucidarme J, Borrow R, Breuer J.

Int J Med Microbiol. 2018 Mar;308(2):256-262. doi: 10.1016/j.ijmm.2017.11.004. Epub 2017 Nov 13.

19.

Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric case.

Tanır G, Ozsurekci Y, Lucidarme J, Yaşar Durmuş S, Lekshmi A, Akisoglu Ö, Aycan AE, Borrow R, Ceyhan M.

Hum Vaccin Immunother. 2018 Jan 2;14(1):209-212. doi: 10.1080/21645515.2017.1377380. Epub 2017 Dec 11.

20.

Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab.

Parikh SR, Lucidarme J, Bingham C, Warwicker P, Goodship T, Borrow R, Ladhani SN.

Pediatrics. 2017 Sep;140(3). pii: e20162452. doi: 10.1542/peds.2016-2452. Epub 2017 Aug 11.

21.

Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak?

Lucidarme J, Lekshmi A, Parikh SR, Bray JE, Hill DM, Bratcher HB, Gray SJ, Carr AD, Jolley KA, Findlow J, Campbell H, Ladhani SN, Ramsay ME, Maiden MCJ, Borrow R.

J Infect. 2017 Aug;75(2):95-103. doi: 10.1016/j.jinf.2017.05.015. Epub 2017 Jun 1.

22.

Hierarchical genomic analysis of carried and invasive serogroup A Neisseria meningitidis during the 2011 epidemic in Chad.

Diallo K, Gamougam K, Daugla DM, Harrison OB, Bray JE, Caugant DA, Lucidarme J, Trotter CL, Hassan-King M, Stuart JM, Manigart O, Greenwood BM, Maiden MCJ.

BMC Genomics. 2017 May 22;18(1):398. doi: 10.1186/s12864-017-3789-0.

23.

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment.

Parikh SR, Newbold L, Slater S, Stella M, Moschioni M, Lucidarme J, De Paola R, Giuliani M, Serino L, Gray SJ, Clark SA, Findlow J, Pizza M, Ramsay ME, Ladhani SN, Borrow R.

Lancet Infect Dis. 2017 Jul;17(7):754-762. doi: 10.1016/S1473-3099(17)30170-6. Epub 2017 Mar 30.

PMID:
28366725
24.

Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa.

Ganesh K, Allam M, Wolter N, Bratcher HB, Harrison OB, Lucidarme J, Borrow R, de Gouveia L, Meiring S, Birkhead M, Maiden MC, von Gottberg A, du Plessis M.

BMC Microbiol. 2017 Feb 21;17(1):40. doi: 10.1186/s12866-017-0942-5.

25.

An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015.

Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, Jacobsson S, Fredlund H, Cameron JC, Smith-Palmer A, McMenamin J, Gray SJ, Campbell H, Ladhani S, Findlow J, Mölling P, Borrow R.

Euro Surveill. 2016 Nov 10;21(45). pii: 30395. doi: 10.2807/1560-7917.ES.2016.21.45.30395.

26.

Authors' response: Meningococcal vaccine antigen diversity in global databases.

Brehony C, Hill DM, Lucidarme J, Borrow R, Maiden MC.

Euro Surveill. 2016 Apr 14;21(15). doi: 10.2807/1560-7917.ES.2016.21.15.30192. No abstract available.

27.

Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution.

Clark SA, Lekshmi A, Lucidarme J, Hao L, Tsao H, Lee-Jones L, Jansen KU, Newbold LS, Anderson AS, Borrow R.

J Infect. 2016 Jul;73(1):63-70. doi: 10.1016/j.jinf.2016.03.012. Epub 2016 Mar 26.

PMID:
27025206
28.

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England.

Ladhani SN, Giuliani MM, Biolchi A, Pizza M, Beebeejaun K, Lucidarme J, Findlow J, Ramsay ME, Borrow R.

Emerg Infect Dis. 2016 Feb;22(2):309-11. doi: 10.3201/eid2202.150369.

29.

Meningococcal vaccine antigen diversity in global databases.

Brehony C, Hill DM, Lucidarme J, Borrow R, Maiden MC.

Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30084.

30.

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.

Hill DM, Lucidarme J, Gray SJ, Newbold LS, Ure R, Brehony C, Harrison OB, Bray JE, Jolley KA, Bratcher HB, Parkhill J, Tang CM, Borrow R, Maiden MC.

Lancet Infect Dis. 2015 Dec;15(12):1420-8. doi: 10.1016/S1473-3099(15)00267-4. Epub 2015 Oct 27. Erratum in: Lancet Infect Dis. 2016 Jan;16(1):16. Lancet Infect Dis. 2016 Jan;16(1):16.

31.

Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage.

Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, Vazquez JA, Taha MK, Ceyhan M, Efron AM, Gorla MC, Findlow J, Jolley KA, Maiden MC, Borrow R.

J Infect. 2015 Nov;71(5):544-52. doi: 10.1016/j.jinf.2015.07.007. Epub 2015 Jul 28.

32.

Oropharyngeal Carriage of Meningococcus in Portugal by Group and Clonal Complex 6 Years After Adolescent Vaccine Campaign.

Rodrigues F, Morales-Aza B, Christensen H, Giles J, Ferreira M, Sikora P, Madanelo I, Lucidarme J, Januário L, Finn A.

Pediatr Infect Dis J. 2015 Nov;34(11):1267-9. doi: 10.1097/INF.0000000000000860.

PMID:
26222062
33.

Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013.

Chatt C, Gajraj R, Hawker J, Neal K, Tahir M, Lawrence M, Gray SJ, Lucidarme J, Carr AD, Clark SA, Fowler T.

Euro Surveill. 2014 Nov 6;19(44). pii: 20949.

34.

Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales.

Ladhani SN, Beebeejaun K, Lucidarme J, Campbell H, Gray S, Kaczmarski E, Ramsay ME, Borrow R.

Clin Infect Dis. 2015 Feb 15;60(4):578-85. doi: 10.1093/cid/ciu881. Epub 2014 Nov 10.

PMID:
25389259
35.

Neisseria adhesin A variation and revised nomenclature scheme.

Bambini S, De Chiara M, Muzzi A, Mora M, Lucidarme J, Brehony C, Borrow R, Masignani V, Comanducci M, Maiden MC, Rappuoli R, Pizza M, Jolley KA.

Clin Vaccine Immunol. 2014 Jul;21(7):966-71. doi: 10.1128/CVI.00825-13. Epub 2014 May 7.

36.

Genotypic analysis of meningococcal factor h-binding protein from non-culture clinical specimens.

Clark SA, Lucidarme J, Newbold LS, Borrow R.

PLoS One. 2014 Feb 24;9(2):e89921. doi: 10.1371/journal.pone.0089921. eCollection 2014.

37.

The distribution and 'in vivo' phase variation status of haemoglobin receptors in invasive meningococcal serogroup B disease: genotypic and phenotypic analysis.

Lucidarme J, Findlow J, Chan H, Feavers IM, Gray SJ, Kaczmarski EB, Parkhill J, Bai X, Borrow R, Bayliss CD.

PLoS One. 2013 Sep 30;8(9):e76932. doi: 10.1371/journal.pone.0076932. eCollection 2013.

38.

Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.

Frosi G, Biolchi A, Lo Sapio M, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, Medini D.

Vaccine. 2013 Oct 9;31(43):4968-74. doi: 10.1016/j.vaccine.2013.08.006. Epub 2013 Aug 14.

39.

Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica.

Lucidarme J, Gilchrist S, Newbold LS, Gray SJ, Kaczmarski EB, Richardson L, Bennett JS, Maiden MC, Findlow J, Borrow R.

Clin Vaccine Immunol. 2013 Sep;20(9):1360-9. doi: 10.1128/CVI.00090-13. Epub 2013 Jun 26.

40.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R.

Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.

PMID:
23414709
41.

Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, Ramsay ME, Kaczmarski EB, Borrow R.

Emerg Infect Dis. 2012 Jan;18(1):63-70. doi: 10.3201/eid1801.110901.

42.

Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.

Lucidarme J, Tan L, Exley RM, Findlow J, Borrow R, Tang CM.

Clin Vaccine Immunol. 2011 Jun;18(6):1002-14. doi: 10.1128/CVI.00055-11. Epub 2011 Apr 20.

43.

Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP.

Lucidarme J, Newbold LS, Findlow J, Gilchrist S, Gray SJ, Carr AD, Hewitt J, Kaczmarski EB, Borrow R.

Clin Vaccine Immunol. 2011 Feb;18(2):194-202. doi: 10.1128/CVI.00401-10. Epub 2010 Dec 1.

44.

Sequence conservation of pilus subunits in Neisseria meningitidis.

Cehovin A, Winterbotham M, Lucidarme J, Borrow R, Tang CM, Exley RM, Pelicic V.

Vaccine. 2010 Jul 5;28(30):4817-26. doi: 10.1016/j.vaccine.2010.04.065. Epub 2010 May 8.

45.

Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine.

Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Borrow R.

Clin Vaccine Immunol. 2010 Jun;17(6):919-29. doi: 10.1128/CVI.00027-10. Epub 2010 Apr 7.

46.

The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.

Kugelberg E, Gollan B, Farrance C, Bratcher H, Lucidarme J, Ibarz-Pavón AB, Maiden MC, Borrow R, Tang CM.

PLoS One. 2010 Feb 25;5(2):e9413. doi: 10.1371/journal.pone.0009413.

47.

Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.

Lucidarme J, Comanducci M, Findlow J, Gray SJ, Kaczmarski EB, Guiver M, Kugelberg E, Vallely PJ, Oster P, Pizza M, Bambini S, Muzzi A, Tang CM, Borrow R.

J Clin Microbiol. 2009 Nov;47(11):3577-85. doi: 10.1128/JCM.00936-09. Epub 2009 Sep 16.

Supplemental Content

Loading ...
Support Center